MA53828A - Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes - Google Patents

Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes

Info

Publication number
MA53828A
MA53828A MA053828A MA53828A MA53828A MA 53828 A MA53828 A MA 53828A MA 053828 A MA053828 A MA 053828A MA 53828 A MA53828 A MA 53828A MA 53828 A MA53828 A MA 53828A
Authority
MA
Morocco
Prior art keywords
plants
compositions
methods
pathogenic infections
treating pathogenic
Prior art date
Application number
MA053828A
Other languages
English (en)
Inventor
Goutam Gupta
Eddie W Stover
Original Assignee
Innate Immunity LLC
Us Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innate Immunity LLC, Us Agriculture filed Critical Innate Immunity LLC
Publication of MA53828A publication Critical patent/MA53828A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00—Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • A01H3/04—Processes for modifying phenotypes, e.g. symbiosis with bacteria by treatment with chemicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8237—Externally regulated expression systems
    • C12N15/8239—Externally regulated expression systems pathogen inducible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA053828A 2018-10-01 2019-10-01 Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes MA53828A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/148,848 US20200102356A1 (en) 2018-10-01 2018-10-01 Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants

Publications (1)

Publication Number Publication Date
MA53828A true MA53828A (fr) 2022-01-05

Family

ID=69945419

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053828A MA53828A (fr) 2018-10-01 2019-10-01 Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes

Country Status (8)

Country Link
US (1) US20200102356A1 (fr)
EP (1) EP3860619A4 (fr)
CN (1) CN113164513A (fr)
AU (1) AU2019351903A1 (fr)
BR (1) BR112021006310A2 (fr)
MA (1) MA53828A (fr)
MX (1) MX2021003849A (fr)
WO (1) WO2020072535A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021246017A1 (en) * 2020-03-31 2022-11-10 Innate Immunity LLC Recombinant peptide to treat fire blight
CN112640711B (zh) * 2020-12-24 2022-09-20 深圳市硒惠农生物科技有限公司 一种防治柚子树黄龙病的方法
CN113402613B (zh) * 2021-01-19 2022-06-14 东北农业大学 抗菌肽ll37活性中心衍生肽二倍体抗菌肽lg及其制备方法和应用
WO2023018876A2 (fr) * 2021-08-11 2023-02-16 The Regents Of The University Of California Peptides pour membranes conservant une fonction barrière
CN114573672B (zh) * 2022-03-21 2022-10-04 中国农业科学院农业基因组研究所 西瓜苦味物质葫芦素e的转运蛋白及其应用
US20250243245A1 (en) * 2022-04-12 2025-07-31 DiverseVitality.com LLC d/b/a/ Diverse Vitality Antibacterial Chimeric Peptides and Their Methods of Therapeutic Use
CN116715733A (zh) * 2022-10-18 2023-09-08 深圳润康生态环境股份有限公司 一种有效抑制柑橘黄龙病病原菌增殖的抗菌肽stj-2及其应用
US20260026500A1 (en) 2022-12-29 2026-01-29 Biotalys NV Agrochemical compositions
EP4642916A2 (fr) 2022-12-30 2025-11-05 Biotalys NV Signaux de sécrétion
EP4642232A1 (fr) 2022-12-30 2025-11-05 Biotalys NV Concentré auto-émulsifiable
EP4642233A1 (fr) 2022-12-30 2025-11-05 Biotalys NV Agglomérat
WO2025133390A1 (fr) 2023-12-22 2025-06-26 Biotalys NV Anticorps vhh antifongiques
WO2025207956A1 (fr) * 2024-03-27 2025-10-02 The Regents Of The University Of California Compositions et procédés de traitement de la maladie du dragon jaune
WO2026008785A1 (fr) 2024-07-03 2026-01-08 Biotalys NV Compositions agrochimiques

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2201421C2 (ru) * 1993-06-09 2003-03-27 Коннот Лабораториз Лимитед Синтетический пептид hiv (варианты), иммуногенная композиция для индукции иммунного ответа против пептидов hiv, диагностический набор для определения hiv-специфичных антител
US8212110B2 (en) * 2003-05-14 2012-07-03 Integrated Plant Genetics, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
WO2004104169A2 (fr) * 2003-05-14 2004-12-02 Integrated Plant Genetics, Inc. Identification et utilisation de genes codant des proteines holines et du type holine dans les plantes pour lutter contre les microbes et les parasites
US9181310B2 (en) * 2003-05-14 2015-11-10 University Of Florida Research Foundation, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
WO2005019242A2 (fr) * 2003-08-18 2005-03-03 E.I. Dupont De Nemours And Company Expression de recombinaison du peptide hag1 anti-microbien: utilisation en tant que partenaire de fusion pour l'expression de peptides alpha helicoidaux antimicrobiens
AU2005231342A1 (en) * 2004-03-29 2005-10-20 The Arizona Board Of Regents On Behalf Of The University Of Arizona Amphipathic glycopeptides
AU2005295640B2 (en) * 2004-10-15 2011-07-28 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multi-domain amphipathic helical peptides and methods of their use
EP1848265A2 (fr) * 2005-01-26 2007-10-31 Washington State University Research Foundation Peptides signal pour la defense de plantes
AU2007307254A1 (en) * 2006-10-05 2008-04-17 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
CA2671358A1 (fr) * 2006-12-21 2008-07-03 Rickey P. Hicks Composes peptidomimetiques antimicrobiens et procedes d'evaluation d'activite antimicrobienne
CN101646771A (zh) * 2007-01-10 2010-02-10 萨斯喀彻温大学 环肽结构的稳定
AU2008251748B2 (en) * 2007-01-16 2014-02-27 C3 Jian, Inc. Novel antimicrobial peptides
GB0821687D0 (en) * 2008-11-28 2008-12-31 Secr Defence Peptides
US8722616B2 (en) * 2009-10-22 2014-05-13 Board Of Regents Of The University Of Nebraska Anti-HIV peptides and methods of use thereof
CN105829336A (zh) * 2013-10-17 2016-08-03 首尔大学校产学协力团 α-螺旋细胞穿透肽多聚体、其产生方法及其用途
CA2964361A1 (fr) * 2014-10-14 2016-04-21 The Usa, As Represented By The Secretary, Dept. Of Health & Human Services Methodes de traitement du cancer du pancreas reposant sur l'administration de peptides
WO2016154328A2 (fr) * 2015-03-23 2016-09-29 Riptide Bioscience, Inc. Peptides antimicrobiens et leurs méthodes d'utilisations
US10611799B2 (en) * 2017-03-03 2020-04-07 National Tsing Hua University Anti-endotoxin polypeptide

Also Published As

Publication number Publication date
EP3860619A4 (fr) 2022-10-26
BR112021006310A2 (pt) 2021-08-31
MX2021003849A (es) 2021-09-08
AU2019351903A1 (en) 2021-05-13
WO2020072535A1 (fr) 2020-04-09
CN113164513A (zh) 2021-07-23
EP3860619A1 (fr) 2021-08-11
US20200102356A1 (en) 2020-04-02

Similar Documents

Publication Publication Date Title
MA53828A (fr) Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes
EP3924481A4 (fr) Compositions et méthodes de traitement d'hémoglobinopathies
EP3846846A4 (fr) Compositions et procédés pour le traitement d'infections virales
EP3490366A4 (fr) Procédés et compositions pour l'expression de gènes dans des plantes
EP3775263A4 (fr) Compositions et méthodes de traitement de l'acné
MA51056A (fr) Compositions et méthodes pour le traitement d'affections métaboliques
MA52861A (fr) Méthodes et compositions pour le traitement de l'apnée du sommeil
EP3668317A4 (fr) Inhibition photodynamique d'agents pathogènes microbiens dans des plantes
EP3641746A4 (fr) Méthodes et compositions pour le traitement d'une infection microbienne
EP3458079A4 (fr) Compositions et méthodes pour le traitement de l'acné
EP3512524A4 (fr) Méthodes et compositions de traitement d'infections virales
EP3634431A4 (fr) Compositions et méthodes thérapeutiques pour le traitement de l'hépatite b
EP3405191A4 (fr) Méthodes et compositions pour le traitement de l'hyperhidrose
EP3651801A4 (fr) Compositions et méthodes pour le traitement d'infections fongiques
EP3810091A4 (fr) Méthodes et compositions pour le traitement de l'hypertension pulmonaire
EP4114422A4 (fr) Compositions et méthodes pour le traitement d'infections bactériennes intracellulaires
EP3400008A4 (fr) Compositions thérapeutiques et méthodes pour le traitement de l'hépatite b
EP3368048A4 (fr) Méthodes et compositions pour le traitement de l'amyloïdose
EP3638270A4 (fr) Compositions et méthodes pour l'amélioration d'un traitement par hyperthermie
EP3595689A4 (fr) Méthodes et compositions pour traiter l'obésité, l'inflammation ou des troubles métaboliques avec des bactériophages
EP3877012A4 (fr) Méthodes et composition pour le traitement d'infections microbiennes
EP3654961A4 (fr) Méthodes et compositions pour le traitement de la douleur à l'aide de la capsaïcine
EP3955738A4 (fr) Compositions et procédés pour moduler l'immunité dans des plantes
EP3638287A4 (fr) Méthodes et compositions pour le traitement d'une inflammation microbienne
EP3373922A4 (fr) Compositions et méthodes pour le traitement de l'homocystinurie